AbbVie Inc.
Pharmaceutical Formulations for Subcutaneous Administration
Last updated:
Abstract:
The present disclosure relates to compositions of levodopa 4'-monophosphate and carbidopa 4'-monophosphate having a weight by weight ratio of about 20:1 and methods of treating Parkinson's disease and associated conditions by subcutaneous administration of such compositions.
Status:
Application
Type:
Utility
Filling date:
15 Nov 2019
Issue date:
21 May 2020